Fcg Investment CO Vertex Pharmaceuticals Inc Transaction History
Fcg Investment CO
- $132 Billion
- Q2 2024
A detailed history of Fcg Investment CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fcg Investment CO holds 3,025 shares of VRTX stock, worth $1.49 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
3,025
Previous 2,310
30.95%
Holding current value
$1.49 Million
Previous $966 Million
46.84%
% of portfolio
1.08%
Previous 0.77%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,649Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.6 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.91 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.49 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...